Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Guillin

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin derivatives obtained by autolytic or limited tryptic cleavageM C Guillin, A Bezeaud
Pathologie-Biologie|October 1, 1985
[General mechanisms of coagulation and their physiological inhibition. I. General mechanisms of blood coagulation]M C Guillin, A Bezeaud
Rheumatic Diseases Clinics of North America|September 6, 2001
Antiphospholipid antibodies and the coagulation cascadeE Anglés-Cano, M C Guillin
Journal of Clinical Microbiology|December 1, 1989
Evaluation of five hepatitis delta virus marker assays for detection of antigen and antibodyA Bezeaud, M Rosenswajg, M C Guillin
Biochimica Et Biophysica Acta|November 20, 1978
The mechanism of activation of human prothrombin by an activator isolated from Dispholidus typus venomM C Guillin, A Bezeaud, D Menache
Blood|March 1, 1988
Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variantA Bezeaud, J Elion, M C Guillin
European Journal of Biochemistry|December 16, 1985
Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulinA Bezeaud, M H Denninger, M C Guillin
Thrombosis Research|October 1, 1986
Prothrombin Clamart: prothrombin variant with defective Arg 320-IIe cleavage by factor XaM G Huisse, M Dreyfus, M C Guillin
Thrombosis Et Diathesis Haemorrhagica|December 31, 1973
Human coumarin prothrombin. Chromatographic, coagulation and immunologic studiesN Cesbron, C Boyer, M C Guillin, et al.
British Journal of Haematology|December 31, 1997
Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activationD Helley, R Girot, M C Guillin, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Seminars in Thrombosis and Hemostasis|January 1, 1992
Thrombin derivatives obtained by autolytic or limited tryptic cleavageM C Guillin, A Bezeaud
Pathologie-Biologie|October 1, 1985
[General mechanisms of coagulation and their physiological inhibition. I. General mechanisms of blood coagulation]M C Guillin, A Bezeaud
Rheumatic Diseases Clinics of North America|September 6, 2001
Antiphospholipid antibodies and the coagulation cascadeE Anglés-Cano, M C Guillin
Journal of Clinical Microbiology|December 1, 1989
Evaluation of five hepatitis delta virus marker assays for detection of antigen and antibodyA Bezeaud, M Rosenswajg, M C Guillin
Biochimica Et Biophysica Acta|November 20, 1978
The mechanism of activation of human prothrombin by an activator isolated from Dispholidus typus venomM C Guillin, A Bezeaud, D Menache
Blood|March 1, 1988
Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variantA Bezeaud, J Elion, M C Guillin
European Journal of Biochemistry|December 16, 1985
Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulinA Bezeaud, M H Denninger, M C Guillin
Thrombosis Research|October 1, 1986
Prothrombin Clamart: prothrombin variant with defective Arg 320-IIe cleavage by factor XaM G Huisse, M Dreyfus, M C Guillin
Thrombosis Et Diathesis Haemorrhagica|December 31, 1973
Human coumarin prothrombin. Chromatographic, coagulation and immunologic studiesN Cesbron, C Boyer, M C Guillin, et al.
British Journal of Haematology|December 31, 1997
Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activationD Helley, R Girot, M C Guillin, et al.
Pageof 8